| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |